Literature DB >> 8985838

Gastrointestinal pH, motility/transit and permeability in cystic fibrosis.

P C Gregory1.   

Abstract

I reviewed the literature (1966-1994) concerning gastrointestinal (GI) pH, motility/transit, and permeability in cystic fibrosis (CF). Most studies reported were performed with very small numbers of patients, but even when considered together the published data do not confirm some generally expressed views on these topics. The only clear findings were a high incidence of gastroesophageal reflux in CF; pre- and postprandial duodenal pH is 1-2 U lower in patients with CF than in healthy controls; and small intestinal paracellular permeability is 4-10 times greater than normal in CF. Some patients showed abnormalities of lower esophageal sphincter pressure and of esophageal motility, but apart from one case study other disturbances of GI motility have not been reported. The results of hydrogen breath tests strongly suggest that oro-cecal transit is slowed in CF, but these results must be confirmed by an alternative test. Measurements of colonic transit and colonic permeability have not been reported. The few studies of gastric emptying reported are controversial. Whether GI pH, apart from duodenal pH, is normal in CF or whether a subset of patients has exceptionally acid intestinal contents requiring specialized pancreatic enzyme supplementation to normalize digestion is not clear. Finally, I briefly discuss the findings in relation to their possible impact on the pathogenesis of fibrosing colonopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8985838     DOI: 10.1097/00005176-199612000-00001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.

Authors:  Rebecca A Keel; Andre Schaeftlein; Charlotte Kloft; J Samuel Pope; R Frederic Knauft; Marianne Muhlebach; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management.

Authors:  Hayat M Mousa; Frederick W Woodley
Journal:  Curr Gastroenterol Rep       Date:  2012-06

4.  Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.

Authors:  Shannon R Christiansen; Alberto Broniscer; J Carl Panetta; Clinton F Stewart
Journal:  Pharmacotherapy       Date:  2009-07       Impact factor: 4.705

5.  Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Lauren Meldi; Eileen Roach; Maureen Flynn; Racquel Sewell
Journal:  PLoS One       Date:  2009-01-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.